Skip to main content
NCBI home page
Springer logoLink to Springer
. 2020 Apr 9;54(5):1225–1226. doi: 10.1007/s43441-020-00150-2

Correction to: An Evaluation of Malaysian Regulatory Process for New Active Substances Approved in 2017 Using the OpERA Methodology

Noraisyah Mohd Sani 1, Neil McAuslane 2,✉, Siti Hidayah Kasbon 1, Rosilawati Ahmad 1, Faridah Aryani Md Yusof 1, Prisha Patel 2
PMCID: PMC7645581  PMID: 32865806

Correction to: Therapeutic Innovation & Regulatory Science 10.1007/s43441-020-00140-4

The authors have revised Fig. 1. The revised Fig. 1 is presented below.

Figure 1.

Figure 1.

Open in a new tab

NPRA Review Process.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Articles from Therapeutic Innovation & Regulatory Science are provided here courtesy of Springer

RESOURCES